IPILIMUMAB

Course overview

IPILIMUMAB IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF METASTATIC MELANOMA. IT IS IN THE CTLA-4 MONOCLONAL ANTIBODY CLASS OF MEDICATIONS. THIS ACTIVITY ILLUSTRATES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR IPILIMUMAB AS A VALUABLE AGENT IN THE MANAGEMENT OF METASTATIC MELANOMA AND SEVERAL OTHER TUMORS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH METASTATIC MELANOMA AND RELATED CONDITIONS.